IMPACT OF CELLULAR METABOLISM ON THE BIOLOGICAL EFFECTS OF BENZO[A]PYRENE AND RELATED HYDROCARBONS^†

REFERENCES

• Committee on Biologic Effects of Atmospheric Pollutants, Particulate Polycyclic Organic Matter, Div. Med. Sci. Natl. Res. Council National Academy of Science, Washington, DC 1972
   Google Scholar
• Hattemer-Frey H. A., Travis C. C. Benzo-a-pyrene: Environmental Partitioning and Human Exposure. Toxicol. Ind. Health 1991; 7: 141–157
   PubMed Web of Science ®Google Scholar
• Baum E. J. Occurrence and Surveillance of Polycyclic Aromatic Hydrocarbons. Polycyclic Hydrocarbons and Cancer, H. V. Gelboin, P. O.P. Ts'o. Academic Press, New York 1978; 45–70
   Google Scholar
• U.S. Department of Health Education and Welfare. Smoking and Health Public Health Service Publ. No. 1103; Report of the Advisory Committee to the Surgeon General of the Public Health Service. U.S. Govt. Printing Office, Washington, DC 1967
   Google Scholar
• Schmeltz I., Hoffmann D., Wynder E. L. Toxic and Tumorigenic Agents in Tobacco Smoke. Analytical Methods and Modes of Origin. Trace Subst. Environ. Health 8, Symp. 1974; 281–295
   Google Scholar
• Pryor W. A. Cigarette Smoke Radical and the Role of Free Radicals in Chemical Carcinogenicity. Environ. Health Perspect. 1997; 105: 875–882
   PubMed Web of Science ®Google Scholar
• Hoffmann D., Schmeltz I., Hecht S. S., Wynder E. L. Tobacco Carcinogenesis. Polycyclic Hydrocarbons and Cancer, H. V. Gelboin, P. O.P. Ts'o. Academic Press, New York 1978; 85–117
   Google Scholar
• Gelboin H. V. Benzo[a]pyrene Metabolism, Activation, and Carcinogenesis: Role and Regulation of Mixed-Function Oxidases and Related Enzymes. Physiol. Rev. 1980; 60: 1107–1166
   PubMed Web of Science ®Google Scholar
• Lehr R. E., Jerina D. M. Relationships of Quantum Mechanical Calculations, Relative Mutagenicity of Benzo[a]anthracene Diol Epoxides, and “Bay Region” Concept of Aromatic Hydrocarbon Carcinogenicity. J. Toxicol. Environ. Health 1977; 2: 1259–1265
   PubMed Web of Science ®Google Scholar
• Lehr R. E., Jerina D. M. Metabolic Activations of Polycyclic Hydrocarbons: Structure-Activity Relationships. Arch. Toxicol. 1977; 39: 1–6
   PubMed Web of Science ®Google Scholar
• Wislocki P. G., Kapitulnik J., Levin W., Lehr R., Schaefer-Ridder M., Karle J. M., Jerina D. M., Conney A. H. Exceptional Carcinogenic Activity of Benz[a]anthracene 3,4-Dihydrodiol in the Newborn Mouse and the Bay Region Theory. Cancer Res. 1978; 38: 693–696
   PubMed Web of Science ®Google Scholar
• Pelkonen O., Nebert D. W. Metabolism of Polycyclic Aromatic Hydrocarbons: Etiologic Role in Carcinogenesis. Pharmacol. Rev. 1982; 34: 189–222
   PubMed Web of Science ®Google Scholar
• Parkinson A. Biotransformation of Xenobiotics. Casarett and Doull's Toxicology, The Basic Science of Poisons, C. D. Klaassen. McGraw-Hill, New York 1996; 113–186
   Google Scholar
• Yang S. K. Stereoselectivity of Cytochrome P-450 Isozymes and Epoxide Hydrolase in the Metabolism of Polycyclic Aromatic Hydrocarbons. Biochem. Pharmacol. 1988; 37: 61–70
   PubMed Web of Science ®Google Scholar
• Selkirk J. K. Benzo[a]pyrene Carcinogenesis: A Biochemical Selection Mechanism. J. Toxicol. Environ. Health 1977; 2: 1245–1258
   PubMed Web of Science ®Google Scholar
• Smithgall T. E., Harvey R. G., Penning T. M. Spectroscopic Identification of Orthoquinones as the Products of Polycyclic Aromatic Trans-dihydrodiol Oxidation Catalyzed by Dihydrodiol Dehydrogenase. A Potential Route of Proximate Carcinogen Metabolism. J. Biol. Chem. 1988; 263: 1814–1820
   PubMed Web of Science ®Google Scholar
• Hollstein M., McCann J., Angelosanto F. A., Nichols W. W. Short-Term Tests for Carcinogens and Mutagens. Mutat. Res. 1979; 65: 133–226
   PubMed Web of Science ®Google Scholar
• Huang A. L., Berard D., Hager G. L. Glucocorticoid Regulation of the HaMuSV p21 Gene Conferred by Sequences from Mouse Mammary Tumor Virus. Cell 1981; 27: 245–255
   PubMed Web of Science ®Google Scholar
• Borgen A., Darvey H., Castagnoli N., Crocker T. T., Rasmussen R. E., Wang I. T. Metabolic Conversion of Benzo[a]pyrene by Syrian Hamster Liver Microsomes and Binding Metabolites to Deoxyribonucleic Acid. J. Med. Chem. 1973; 16: 502–506
   PubMed Web of Science ®Google Scholar
• Selkirk J. K., Croy R. G., Roller P. P., Gelboin H. V. High-Pressure Liquid Chromatographic Analysis of Benzo(a)pyrene Metabolism and Covalent Binding and the Mechanism of Action of 7,8-benzoflavone and 1,2-epoxy-3,3,3-trichloropropane. Cancer Res. 1974; 34: 3474–3480
   PubMed Web of Science ®Google Scholar
• Cavalieri E. L., Rogan E. G. The Approach to Understanding Aromatic Hydrocarbon Carcinogenesis: The Central Role of Radical Cations in Metabolic Activation. Pharmacol. Ther. 1992; 55: 183–199
   PubMed Web of Science ®Google Scholar
• Lesko S., Caspary W., Lorentzen R., Ts'o P. O.P. Enzymic Formation of 6-oxobenzo[a]pyrene Radical in Rat Liver Homogenates from Carcinogenic Benzo[a]pyrene. Biochemistry 1975; 14: 3978–3984
   Web of Science ®Google Scholar
• Rogan E., Roth R., Katomski P., Benderson J., Cavalieri E. Binding of Benzo[a]pyrene at the 1,3,6 Positions to Nucleic Acids in vivo on Mouse Skin and in vitro with Rat Liver Microsomes and Nuclei. Chem. Biol. Interact. 1978; 22: 35–51
   PubMed Web of Science ®Google Scholar
• Sullivan P. D. Free Radicals of Benzo[a]pyrene and Derivatives. Environ. Health Perspect. 1985; 64: 283–295
   PubMed Web of Science ®Google Scholar
• Sullivan P. D., Calle L. M., Shafer K., Nettleman M. Effect of Antioxidants on Benzo[a]pyrene Free Radicals. Carcinogenesis: A Comprehensive Survey, P. W. Jones, R. I. Freudenthal. Raven Press, New York 1978; 1–8
   Google Scholar
• Krzywanska E., Piekarski L. Benzo[a]pyrene Free Radicals Formation in the Presence of Butylated Hydroxyanisole and their Possible Importance in Carcinogenesis. Neoplasma 1977; 24: 395–400
   PubMed Web of Science ®Google Scholar
• Lesko S. A., Lorentzen R. J. Benzo[a]pyrene dione-Benzo[a]pyrene diol Oxidation-Reduction Couples; Involvement in DNA Damage, Cellular Toxicity, and Carcinogenesis. J. Toxicol. Environ. Health 1985; 16: 679–691
   PubMed Web of Science ®Google Scholar
• Lorentzen R. J., Ts'o P. O.P. Benzo[a]pyrenedione/benzo[a]pyrenediol Oxidation-Reduction Couples and the Generation of Reactive Reduced Molecular Oxygen. Biochemistry 1977; 16: 1467–1473
   PubMed Web of Science ®Google Scholar
• Booth J., Sims P. Different Pathways Involved in the Metabolism of the 7,8- and 9,10-dihydrodiols of Benzo[a]pyrene. Biochem. Pharmacol. 1976; 25: 979–980
   PubMed Web of Science ®Google Scholar
• Thakker D. R., Yagi H., Lehr R. E., Kevin W., Buening M., Lu A. Y.H., Chang R. L., Wood A. W., Conney A. H., Jerina D. M. Metabolism of Trans-9,10-dihydroxy-9,10-dihydrobenzo[a]pyrene Occurs Primarily by Arylhydroxylation Rather Than Formation of a Diol Epoxide. Mol. Pharmacol. 1978; 14: 502–513
   PubMed Web of Science ®Google Scholar
• Capdevila J., Estabrook R. W., Prough R. A. The Microsomal Metabolism of Benzo[a]pyrene Phenols. Biochem. Biophys. Res. Commun. 1978; 82: 518–525
   PubMed Web of Science ®Google Scholar
• Slaga T. J., Bracken W. M., Gleason G., Levin W., Yagi H., Jerina D. M., Conney A. H. Marked Differences in Skin Tumor-Initiating Activities of the Optical Enantiomers of the Diastereomeric Benzo[a]pyrene 7,8-diol-9,10-epoxides. Cancer Res. 1979; 39: 67–71
   PubMed Web of Science ®Google Scholar
• Huberman E., Sachs L., Yang S. K., Gelboin H. V. Identification of Mutagenic Metabolites of Benzo[a]pyrene in Mammalian Cells. Proc. Natl. Acad. Sci. USA 1976; 73: 607–611
   PubMed Web of Science ®Google Scholar
• Flowers N. L., Miles P. R. Alterations of Pulmonary Benzo[a]pyrene Metabolism by Reactive Oxygen Metabolites. Toxicology 1991; 68: 259–274
   PubMed Web of Science ®Google Scholar
• Kim K. B., Lee B. M. Oxidative Stress to DNA, Protein, and Antioxidant Enzymes (Superoxide Dismutase and Catalase) in Rats Treated with Benzo[a]pyrene. Cancer Lett. 1997; 113: 205–212
   PubMed Web of Science ®Google Scholar
• Chouroulinkov I., Gentil A., Grover P. L., Sims P. Tumour Initiating Activities on Mouse Skin of Dihydrodiols Derived from Benz[a]pyrene. Br. J. Cancer 1976; 34: 523–532
   PubMed Web of Science ®Google Scholar
• Levin W., Wood A. W., Chang R. L., Slaga T. J., Yagi H., Jerina D. M., Conney A. H. Marked Differences in the Tumor-Initiating Activity of Optically Pure (+)- and (−)-Trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene on Mouse Skin. Cancer Res. 1977; 37: 2721–2725
   PubMed Web of Science ®Google Scholar
• Glatt H. R., Oesch F. Phenolic Benzo[a]pyrene Metabolites Are Mutagens. Mutat. Res. 1976; 36: 379–384
   PubMed Web of Science ®Google Scholar
• Wislocki P. G., Wood A. W., Chang R. L., Levin W., Tagi H., Hernandez O., Dansette P. M., Jerina D. M., Conney A. H. Mutagenicity and Cytotoxicity of Benzo[a]pyrene Arene Oxides, Phenols, Quinones, and Dihydrodiols in Bacterial and Mammalian cells. Cancer Res. 1976; 36: 3350–3357
   PubMed Web of Science ®Google Scholar
• Slaga T. J., Bracken W. M., Viaje A., Berry D. L., Gischer S. M., Miller D. R., Levin W., Conney A. H., Yagi H., Jerina D. M. Tumor Initiating and Promoting Activities of Various Benzo[a]pyrene Metabolites in Mouse Skin. Polynuclear Aromatic Hydrocarbons: Carcinogenesis: A Comprehensive Survey, P. W. Jones, R. I. Freudenthal. Raven Press, New York 1978; 371–382
   Google Scholar
• Zhu H., Li Y., Trush M. A. Characterization of Benzo[a]pyrene Quinone-Induced Toxicity to Primary Cultured Bone Marrow Stromal Cells from DBA/2 Mice: Potential Role of Mitochondrial Dysfunction. Toxicol. Appl. Pharmacol. 1995; 130: 108–120
   PubMed Web of Science ®Google Scholar
• Roth R. A., Vinegar A. Action by the Lungs on Circulating Xenobiotic Agents, with a Case Study of Physiologically Based Pharmacokinetic Modeling of Benzo(a)pyrene Disposition. Pharmacol. Therap. 1990; 48: 143–155
   PubMed Web of Science ®Google Scholar
• Recio L., Hsie A. W. Glucuronide Conjugation Reduces the Cytotoxicity But Not the Mutagenicity of Benzo[a]pyrene in the CHO/HGPRT Assay. Teratog. Carcinog. Mutagen. 1984; 4: 391–402
   PubMedGoogle Scholar
• Kensler T. W., Guyton K. Z. Modulation of Carcinogenesis by Antioxidants. Biological Consequences of Oxidative Stress, L. Spatz, A. D. Bloom. Oxford University Press, New York 1992; 162–185
   Google Scholar
• Byczkowski J. Z., Gessner T. Effects of Inhibition of NADPH:cytochrome P-450 Reductase on Benzo[a]pyrene Metabolism in Mouse Liver Microsomes. Int. J. Biochem. 1989; 21: 525–529
   PubMedGoogle Scholar
• Weyand E. H., Bevan D. R. Benzo[a]pyrene Disposition and Metabolism in Rats Following Intratracheal Instillation. Cancer Res. 1986; 46: 5655–5661
   PubMed Web of Science ®Google Scholar
• Weyand E. H., Bevan D. R. Benzo[a]pyrene Metabolism in vivo Following Intratracheal Administration. Polynuclear Aromatic Hydrocarbons: A Decade of Progress. Proceedings of the 10th International Symposium, M. Cooke, A. J. Dennis. Batelle Press, Columbus, Ohio 1988; 913–923
   Google Scholar
• Sun J. D., Wolff R. K., Kanapilly G. M. Deposition, Retention, and Biological Fate in Inhaled Benzo-a-pyrene Adsorbed onto Ultrafine Particles and as a Pure Aerosol. Toxicol. Appl. Pharmacol. 1982; 65: 231–244
   PubMed Web of Science ®Google Scholar
• Rahman A., Barrowman J. A., Rahimtula A. The Influence of Bile on the Bioavailability of Polynuclear Aromatic Hydrocarbons from the Rat Intestine. Can. J. Physiol. Pharmacol. 1986; 64: 1214–1218
   PubMed Web of Science ®Google Scholar
• Yamazaki H., Terada M., Tsuboi A., Matsubara C., Hata T., Kakiuchi Y. Distribution and Binding Pattern of Benzo[a]pyrene in Rat Liver, Lung and Kidney Constituents After Oral Administration. Toxicol. Environ. Chem. 1987; 15: 71–81
   Web of Science ®Google Scholar
• Barhoumi R., Mouneimne Y., Ramos K. S., Safe S. H., Phillips T. D., Centonze V. E., Ainley C., Gupta M. S., Burghardt R. C. Analysis of Benzo[a]pyrene Partitioning and Cellular Homeostasis in a Rat Liver Cell Line. Toxicol. Sci. 2000; 53: 264–270
   PubMed Web of Science ®Google Scholar
• Fahl W. E., Jefcoate C. R., Kasper C. B. Characteristics of Benzo[a]pyrene Metabolism and Cytochrome P-450 Heterogeneity in Rat Liver Nuclear Envelope and Comparison to Microsomal Membrane. J. Biol. Chem. 1978; 253: 3106–3113
   PubMed Web of Science ®Google Scholar
• Kasper C. Biochemical Distinctions between the Nuclear and Microsomal Membranes from Rat Hepatocytes. J. Biol. Chem. 1971; 246: 577–581
   PubMed Web of Science ®Google Scholar
• Khandwala A. S., Kasper C. B. Preferential Induction of Aryl Hydroxylase Activity in Rat Liver Nuclear Envelope by 3-methylcholanthrene. Biochem. Biophys. Res. Commun. 1973; 54: 1241–1246
   PubMed Web of Science ®Google Scholar
• Rogan E., Roth R., Cavalieri E. Enzymology of Polycyclic Hydrocarbon Binding to Nucleic Acids. Carcinogenesis, P. W. Jones, R. Freudenthal. Raven Press, New York 1978; 265–271
   Google Scholar
• Sikstrom R., Lanoix J., Bergeron J. J.M. An Enzymatic Analysis of a Nuclear Envelope Fraction. Biochim. Biophys. Acta 1976; 448: 88–102
   PubMed Web of Science ®Google Scholar
• Bresnick E., Stoming T. A., Vaught J. B., Thakkar D. R., Jerina D. M. Nuclear Metabolism of Benzo[a]pyrene and (±)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene. Arch. Biochem. Biophys. 1977; 183: 31–37
   PubMed Web of Science ®Google Scholar
• Ross J. A., Nesnow S. 32P-postlabeling in Studies of Polycyclic Aromatic Hydrocarbon Activation. IARC Scientif. Public. (Lyon) 1993; 124: 71–78
   PubMedGoogle Scholar
• Talaska G., Jaeger M., Reilman R., Collins T., Warshawsky D. Chronic, Topical Exposure to Benzo[a]pyrene Induces Relatively High Steady-State Levels of DNA Adducts in Target Tissues and Alters Kinetics of Adduct Loss. Proc. Natl. Acad. Sci. USA 1996; 93: 7789–7793
   PubMed Web of Science ®Google Scholar
• Conney A. H., Chang R. L., Jerina D. M., Wei S.-J. C. Studies on the Metabolism of Benzo[a]pyrene and Dose-Dependent Differences in the Mutagenic Profile of Its Ultimate Carcinogenic Metabolite. Drug Metab. Rev. 1994; 26: 125–163
   PubMed Web of Science ®Google Scholar
• Szeliga J., Dipple A. DNA Adduct Formation by Polycyclic Aromatic Hydrocarbon Dihydrodiol Epoxides. Chem. Res. Toxicol. 1998; 11: 1–11
   PubMed Web of Science ®Google Scholar
• Scharping C. E., McManus M. E., Holder G. M. NADPH-Supported and Arachidonic Acid-Supported Metabolism of the Enantiomers of trans-7,8-dihydrobenzo[a]pyrene-7,8-diol by Human Liver Microsomal Samples. Carcinogenesis 1992; 13: 1199–1207
   PubMed Web of Science ®Google Scholar
• Wood A. W., Chang R. L., Levin W., Yagi H., Thakker D. R., Jerina D. M., Conney A. H. Differences in Mutagenicity of the Optical Enantiomers of the Diastereomeric Benzo[a]pyrene 7,8-diol-9,10-epoxides. Biochem. Biophys. Res. Commun. 1997; 77: 1389–1396
   Google Scholar
• Buening M. K., Wislocki P. G., Levin W., Yahi H., Thakker D. R., Akagi H., Koreeda M., Jerina D. M., Conney A. H. Tumorigenicity of the Optical Enantiomers of the Diastereomeric Benzo[a]pyrene 7,8-diol-9,10-epoxides in Newborn Mice: Exceptional Activity of (+)-7b,8a-dihydroxy-9a,10a-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene. Proc. Natl. Acad. Sci. USA 1978; 75: 5358–5361
   PubMed Web of Science ®Google Scholar
• Meehan T., Straub K., Calvin M. Benzo[a]pyrene Diol Epoxide Covalently Binds to Deoxyguanosine and Deoxyadenosine in DNA. Nature 1977; 269: 725–727
   PubMed Web of Science ®Google Scholar
• Bigger C. A.H., Sawicki J. T., Blake D. M., Raymond L. G., Dipple A. Products of Binding of 7,12-dimethylbenz[a]anthracene to DNA in Mouse Skin. Cancer Res. 1983; 49: 5647–5651
   Google Scholar
• Iball J. A Refinement of the Structure of 9:10-dimethyl-1:2-benzanthracene. Nature 1964; 201: 916–917
   PubMed Web of Science ®Google Scholar
• Devanesan P., RamaKrishna N. V.S., Padmavathi N. S., Rogan E., Cavalieri E. Formation of Benzo[a]pyrene (BP)-DNA Adducts in Mouse Skin by One-Electron Oxidation. Proc. Am. Ass. Cancer Res. 1992; 32: 135
   Google Scholar
• Arif J. M., Shappell N., Sikka H. C., Kumar S., Gupta R. C. 32P-Postlabeling Analysis of Lipophilic DNA Adducts Resulting from Interaction with (±)-3-hydroxy-trans-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene. Chem. Biol. Interact. 1999; 118: 87–97
   PubMed Web of Science ®Google Scholar
• Joseph P., Jaiswal A. K. NAD(P)H:Quinone Oxidoreductase1 (DT Diaphorase) Specifically Prevents the Formation of Benzo[a]pyrene Quinone-DNA Adducts Generated by Cytochrome P450IA1 and P450 Reductase. Proc. Natl. Acad. Sci. USA 1994; 91: 8413–8417
   PubMed Web of Science ®Google Scholar
• Nagata C., Kodama M., Ioki Y. Electron Spin Resonance Study of the Binding of the 6-oxybenzo[a]pyrene Radical and Benzo[a]pyrenesemiquinone Radicals with DNA and Polynucleotides. Polycyclic Hydrocarbons and Cancer, H. V. Gelboin, P. O.P. Ts'o. Academic Press, New York 1978; 247–260
   Google Scholar
• Kodama M., Ioki Y., Nagata C. Binding of Benzo[a]pyrenesemiquinone Radicals with DNA and Polynucleotides. Gann 1977; 68: 253–254
   PubMedGoogle Scholar
• Kodama M., Nagata C. Binding of 6-oxybenzo[a]pyrene Radical with DNA and Polynucleotides. Gann 1977; 68: 125–126
   PubMedGoogle Scholar
• Borm P. J., Knaapen A. M., Schins R. P., Godschalk R. W., Schooten F. J. Neutrophils Amplify the Formation of DNA Adducts by Benzo[a]pyrene in Lung Target Cells. Environ. Health Perspect. 1997; 105(Suppl 5)1089–1093
   PubMedGoogle Scholar
• Feldman G., Remsen J., Shinohara K., Cerutti P. Excisability and Persistence of Benzo[a]pyrene DNA Adducts in Epithelioid Human Lung Cells. Nature 1978; 274: 796–798
   PubMed Web of Science ®Google Scholar
• Pelkonen O., Boobis A. R., Levitt R. C., Kouri R. E., Nebert D. W. Genetic Differences in the Metabolic Activation of Benzo[a]pyrene in Mice. Attempts to Correlate Tumorigenesis with Mutagenesis in vitro. Pharmacology 1979; 18: 281–293
   PubMed Web of Science ®Google Scholar
• King H. W., Thompson M. H., Brookes P. The Role of 9-hydroxy-benzo[a]pyrene in the Microsome Mediated Binding of Benzo[a]pyrene to DNA. Int. J. Cancer 1976; 18: 339–344
   PubMed Web of Science ®Google Scholar
• Kinoshita N., Gelboin H. V. Beta-Glucuronidase Catalyzed Hydrolysis of Benzo[a]pyrene-3-glucuronide and Binding to DNA. Science 1978; 199: 307–309
   PubMed Web of Science ®Google Scholar
• Levin W., Wood A. W., Wislocki P. G., Chang R. L., Kapitulnik J., Mah H. D., Yagi H., Jerina D. M., Conney A. H. Mutagenicity and Carcinogenicity of Benzo[a]pyrene Derivatives. Polycyclic Hydrocarbons and Cancer, H. V. Gelboin, P. O.P. Ts'o. Academic Press, New York 1978; 189–202
   Google Scholar
• Chesis P. L., Levin D. E., Smith M. T., Ernster L., Ames B. N. Mutagenicity of Quinones: Pathways of Metabolic Activation and Detoxification. Proc. Natl. Acad. Sci. USA 1984; 81: 1696–1700
   PubMed Web of Science ®Google Scholar
• Hakura A., Tsutsui Y., Sonoda J., Kai J., Imade T., Shimada M., Sugihara Y., Mikami T. Comparison between in vivo Mutagenicity and Carcinogenicity in Multiple Organs by Benzo[a]pyrene in the lacZ Transgenic Mouse (Muta Mouse). Mutat. Res. 1998; 398: 123–130
   PubMed Web of Science ®Google Scholar
• Schmidt J. V., Bradfield C. A. Ah Receptor Signaling Pathways. Annu. Rev. Cell Dev. Biol. 1996; 12: 55–89
   PubMed Web of Science ®Google Scholar
• Denison M. S., Fisher J. M., Whitlock J. P., Jr. The DNA Recognition Site for the Dioxin-Ah Receptor Complex. J. Biol. Chem. 1988; 263: 17221–17224
   PubMed Web of Science ®Google Scholar
• Denison M. S., Fisher J. M., Whitlock J. P., Jr. Inducible, Receptor-Dependent Protein-DNA Interactions at a Dioxin-Responsive Transcriptional Enhancer. Proc. Natl. Acad. Sci. USA 1988; 85: 2528–2532
   PubMed Web of Science ®Google Scholar
• Fujisawa-Sehara A., Yamane M., Fujii-Kuriyama Y. A DNA-Binding Factor Specific for Xenobiotic Responsive Elements of P-450c Gene Exists as a Cryptic Form in Cytoplasm: Its Possible Translocation to the Nucleus. Proc. Natl. Acad. Sci. USA 1988; 85: 5859–5863
   PubMed Web of Science ®Google Scholar
• Paulson K. E., Darnell J. E., Jr., Rushmore T., Pickett C. B. Analysis of the Upstream Elements of the Xenobiotic Compound-Inducible and Positionally Regulated Glutathione S-Transferase Ya Gene. Mol. Cell. Biol. 1990; 10: 1841–1852
   PubMed Web of Science ®Google Scholar
• Favreau L. V., Pickett C. B. Transcriptional Regulation of the Rat NAD(P)H:Quinone Reductase Gene. Identification of Regulatory Elements Controlling Basal Level Expression and Inducible Expression by Planar Aromatic Compounds and Phenolic Antioxidants. J. Biol. Chem. 1991; 266: 4556–4561
   PubMed Web of Science ®Google Scholar
• Asman D. C., Takimoto K., Pitot H. C., Dunn T. J., Lindahl R. Organization and Characterization of the Rat Class 3 Aldehyde Dehydrogenase Gene. J. Biol. Chem. 1993; 268: 12530–12536
   PubMed Web of Science ®Google Scholar
• Jaiswal A. K. Human NAD(P)H:Quinone Oxidoreductase2: Gene Structure, Activity, and Tissue Specific Expression. J. Biol. Chem. 1994; 269: 14502–14508
   PubMed Web of Science ®Google Scholar
• Vaziri C., Faller D. V. A Benzo[a]pyrene-Induced Cell Cycle Checkpoint Resulting in p53-Independent G1 Arrest in 3T3 Fibroblasts. J. Biol. Chem. 1997; 272: 2762–2769
   PubMed Web of Science ®Google Scholar
• Zhao W., Ramos K. S. Inhibition of DNA Synthesis in Primary Cultures of Adult Rat Hepatocytes by Benzo[a]pyrene and Related Aromatic Hydrocarbons: Role of Ah Receptor-Dependent Events. Toxicology 1995; 99: 179–189
   PubMed Web of Science ®Google Scholar
• Zhao W., Ramos K. S. Modulation of Hepatocyte Gene Expression by the Carcinogen Benzo[a]pyrene. Toxicol. In Vitro 1998; 12: 395–402
   PubMed Web of Science ®Google Scholar
• Spatz L. Biological Consequences of Oxidative Stress, L. Spatz, A. D. Bloom. Oxford University Press, New York 1992; 3–22
   Google Scholar
• Chen Y.-H., Ramos K. S. Negative Regulation of Rat GST-Ya Via Antioxidant/Electrophile Response Elements is Directed by a C/EBP-Like Site. Biochem. Biophys. Res. Comm. 1999; 265: 18–23
   PubMed Web of Science ®Google Scholar
• Miller K. P., Chen Y.-H., Hastings V. L., Bral C. M., Ramos K. S. Profiles of ARE/EpRE Nuclear Protein Binding and c-Ha-ras Transactivation in Vascular Smooth Muscle Cells Treated with Oxidative Metabolites of Benzo[a]pyrene. Biochem. Pharmacol. 2000; 60: 1285–1296
   PubMed Web of Science ®Google Scholar
• Bral C. M., Ramos K. S. Identification of Benzo[a]pyrene-Inducible cis-acting Elements within c-Ha-ras Transcriptional Regulatory Sequences. Mol. Pharmacol. 1997; 52: 974–982
   PubMed Web of Science ®Google Scholar
• Liu S., Pickett C. B. The Rat Liver Glutathione S-Transferase Ya Subunit Gene: Characterization of the Binding Properties of a Nuclear Protein from HepG2 Cells that has High Affinity for the Antioxidant Response Element. Biochemistry 1996; 35: 11517–11521
   PubMed Web of Science ®Google Scholar
• Taniguchi N., Pickett C. B., Griffith O. W. Oxy Radicals and Antioxidative Responses in Cancer: 12th Sapporo Cancer Seminar. Cancer Res. 1993; 53: 3207–3210
   PubMed Web of Science ®Google Scholar
• Rushmore T. H., Morton M. R., Pickett C. B. The Antioxidant Responsive Element. J. Biol. Chem. 1991; 266: 11632–11639
   PubMed Web of Science ®Google Scholar
• Favreau L. V., Pickett C. B. The Rat Quinone Reductase Antioxidant Response Element. J. Biol. Chem. 1995; 270: 24468–24474
   PubMed Web of Science ®Google Scholar
• Friling R. S., Bensimon A., Tichauer Y., Daniel V. Xenobiotic-Inducible Expression of Murine Glutathione S-Transferase Ya Subunit Gene Is Controlled by an Electrophile-Responsive Element. Proc. Natl. Acad. Sci. USA 1990; 87: 6258–6262
   PubMed Web of Science ®Google Scholar
• Xie T., Belinsky M., Xu Y., Jaiswal A. K. ARE- and TRE-mediated Regulation of Gene Expression: Response to Xenobiotics and Antioxidants. J. Biol. Chem. 1995; 270: 6894–6900
   PubMed Web of Science ®Google Scholar
• Venugopal R., Jaiswal A. K. Nrf1 and Nrf2 Positively and c-Fos and Fra1 Negatively Regulate the Human Antioxidant Response Element-Mediated Expression of NAD(P)H:Quinone Oxidoreductase1 Gene. Proc. Natl. Acad. Sci. USA 1996; 93: 14960–14965
   PubMed Web of Science ®Google Scholar
• Wasserman W. W., Fahl W. E. Comprehensive Analysis of Proteins Which Interact with the Antioxidant Responsive Element: Correlation of ARE-BP-1 with the Chemoprotective Induction Response. Arch. Biochem. Biophys. 1997; 344: 387–396
   PubMed Web of Science ®Google Scholar
• Mulcahy R. T., Wartman M. A., Bailey H. H., Gipp J. J. Constitutive and Beta-naphthoflavone-Induced Expression of the Human Gamma-Glutamylcysteine Synthetase Heavy Subunit Gene Is Regulated by a Distal Antioxidant Response Element/TRE Sequence. J. Biol. Chem. 1997; 272: 7445–7454
   PubMed Web of Science ®Google Scholar
• Moehlenkamp J. D., Johnson J. A. Activation of Antioxidant/Electrophile-Responsive Elements in IMR-32 Human Neuroblastoma Cells. Arch. Biochem. Biophys. 1999; 363: 98–106
   PubMed Web of Science ®Google Scholar
• Rushmore T. H., King R. G., Paulson K. E., Pickett C. B. Regulation of Glutathione S-Transferase Ya Subunit Gene Expression: Identification of a Unique Xenobiotic Responsive Element Controlling Inducible Expression by Planar Aromatic Compounds. Proc. Natl. Acad. Sci. USA 1990; 87: 3826–3830
   PubMed Web of Science ®Google Scholar
• Rushmore T. H., Pickett C. B. Transcriptional Regulation of the Rat Glutathione S-Transferase Ya Subunit Gene. Characterization of a Xenobiotic-Responsive Element Controlling Inducible Expression by Phenolic Antioxidants. J. Biol. Chem. 1990; 265: 14648–14653
   PubMed Web of Science ®Google Scholar
• Favreau L. V., Pickett C. B. Transcriptional Regulation of the Rat NAD(P)H:Quinone Reductase Gene. J. Biol. Chem. 1993; 268: 19875–19881
   PubMed Web of Science ®Google Scholar
• Li Y., Jaiswal A. K. Regulation of Human NAD(P)H:Quinone Oxidoreductase Gene. J. Biol. Chem. 1992; 267: 15097–15104
   PubMed Web of Science ®Google Scholar
• Romero D. L., Mounho B. J., Lauer F. T., Born J. L., Burchiel S. W. Depletion of Glutathione by Benzo[a]pyrene Metabolites, Ionomycin, Thapsigargin, and Phorbol Myristate in Human Peripheral Blood Mononuclear Cells. Toxicol. Appl. Pharmacol. 1997; 144: 62–69
   PubMed Web of Science ®Google Scholar
• DiGiovanni J., Gill R. D., Nettikumara A. N., Colby A. B., Reiners J. J., Jr. Effect of Extracellular Calcium Concentration on the Metabolism of Polycyclic Aromatic Hydrocarbons by Cultured Mouse Keratinocytes. Cancer Res. 1989; 49: 5567–5574
   PubMed Web of Science ®Google Scholar
• Boyle W. J., Smocal T., Defize L. H.K., Angel P., Woodgett J. R., Karin M., Hunter T. Activation of Protein Kinase C Decreases Phosphorylation of c-Jun at Sites That Negatively Regulate Its DNA-Binding Activity. Cell 1991; 64: 573–584
   PubMed Web of Science ®Google Scholar
• Baudoin-Legros M., Paquet J. L., Brunelle G., Meyer P. Role of Nuclear Protooncogenes in the Proliferation of Aortic Smooth Muscle Cells in Spontaneously Hypertensive Rats. J. Hypertens. 1989; 7(Suppl. 6)114–115
   Google Scholar
• Kovary K., Bravo R. Expression of Different Jun and Fos Proteins During the G0-to-G1 Transition in Mouse Fibroblasts: in vitro and in vivo Associations. Mol. Cell. Biol. 1991; 11: 2451–2459
   PubMedGoogle Scholar
• Ou X., Ramos K. S. Benzo[a]pyrene Inhibits Protein Kinase C Activity in Subcultured Rat Aortic Smooth Muscle Cells. Chem. Biol. Interact. 1994; 93: 29–40
   PubMed Web of Science ®Google Scholar
• Ou X., Weber T. J., Chapkin R. S., Ramos K. S. Interference with Protein Kinase C-Related Signal Transduction in Vascular Smooth Muscle Cells by Benzo[a]pyrene. Arch. Biochem. Biophys. 1995; 318: 122–130
   PubMed Web of Science ®Google Scholar
• DiGiovanni J., Rho O., Xian W., Beltran L. Role of the Epidermal Growth Factor Receptor and Transforming Growth Factor Alpha in Mouse Skin Carcinogenesis. Prog. Clin. Biol. Res. 1994; 387: 113–138
   PubMedGoogle Scholar
• Tannheimer S. L., Ethier S. P., Caldwell K. K., Burchiel S. W. Benzo[a]pyrene- and TCDD-Induced Alterations in Tyrosine Phosphorylation and Insulin-Like Growth Factor Signaling Pathways in the MCF-10A Human Mammary Epithelial Cell Line. Carcinogenesis 1998; 19: 1291–1297
   PubMed Web of Science ®Google Scholar
• Zhang L., Connor E. E., Chegini N., Shiverick K. T. Modulation by Benzo[a]pyrene of Epidermal Growth Factor Receptors, Cell Proliferation, and Secretion of Human Chorionic Gonadotropin in Human Placental Cell Lines. Biochem. Pharmacol. 1995; 50: 1171–1180
   PubMed Web of Science ®Google Scholar
• Guyda H. J., Mathieu L., Lai W., Manchester D., Wang S. L., Ogilvie S., Shiverick K. T. Benzo[a]pyrene Inhibits Epidermal Growth Factor Binding and Receptor Autophosphorylation in Human Placental Cell Cultures. Mol. Pharmacol. 1990; 37: 137–143
   PubMed Web of Science ®Google Scholar
• Ivanovic V., Weinstein I. B. Benzo[a]pyrene and Other Inducers of Cytochrome P1-450 Inhibit Binding of Epidermal Growth Factor to Cell Surface Receptors. Carcinogenesis 1982; 3: 505–510
   PubMed Web of Science ®Google Scholar
• Jope R. S., Song L., Grimes C. A., Zhang L. Oxidative Stress Oppositely Modulates Protein Tyrosine Phosphorylation Stimulated by Muscarinic G Protein-Coupled and Epidermal Growth Factor Receptors. J. Neurosci. Res. 1999; 55: 329–340
   PubMed Web of Science ®Google Scholar
• Peus D., Vasa R. A., Meves A., Pott M., Beyerle A., Squillance K., Pittelkow M. R. H2O2 Is an Important Mediator of UVB-Induced EGF-Receptor Phosphorylation in Cultured Keratinocytes. J. Invest. Dermatol. 1998; 110: 966–971
   PubMed Web of Science ®Google Scholar
• Suc I., Meilhac O., Lajoie-Mazenc I., Vandaele J., Jurgens G., Salvayre R. Negre-Salvayre, A Activation of EGF Receptor by Oxidized LDL. FASEB J. 1998; 12: 665–671
   PubMed Web of Science ®Google Scholar
• Liu W., Akhand A. A., Kato M., Yokoyama I., Miyata T., Kurokawa K., Uchida K., Nakashima I. 4-Hydroxynonenal Triggers an Epidermal Growth Factor Receptor-Linked Signal Pathway for Growth Inhibition. J. Cell Sci. 1999; 112: 2409–2417
   PubMed Web of Science ®Google Scholar
• Miller J. A. Carcinogenesis by Chemicals: An Overview—G.H.A. Clowes Memorial Lecture. Cancer Res. 1970; 30: 559–576
   PubMed Web of Science ®Google Scholar
• Miller E. C., Miller J. A. Searches for Ultimate Chemical Carcinogens and Their Reactions with Cellular Macromolecules. Cancer 1981; 47: 2327–2345
   PubMed Web of Science ®Google Scholar
• Toxicological Profile for Polycyclic Aromatic Hydrocarbons. Agency for Toxic Substances and Disease Registry. 1990
   Google Scholar
• Slaga T. J., Bracken W. M., Dresner S., Levin W., Yagi H., Jerina D. M., Conney A. H. Skin Tumor-Initiating Activities of the Twelve Isomeric Phenols of Benzo[a]pyrene. Cancer Res. 1978; 38: 678–681
   PubMed Web of Science ®Google Scholar
• Levin W., Wood A. W., Wislocki P. G., Kapitulnik J., Yagi H., Jerina D. M., Conney A. H. (±)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene: A Potent Skin Carcinogen When Applied Topically to Mice. Proc. Natl. Acad. Sci. USA 1976; 73: 3867–3871
   PubMed Web of Science ®Google Scholar
• Kapitulnik J., Levin W., Conney A. H., Yagi H., Jerina D. M. Benzo[a]pyrene 7,8-dihydrodiol Is More Carcinogenic than Benzo[a]pyrene in Newborn Mice. Nature 1977; 266: 378–380
   PubMed Web of Science ®Google Scholar
• Kadlubar F. F., Badawi A. F. Genetic Susceptibility and Carcinogen-DNA Adduct Formation in Human Urinary Bladder Carcinogenesis. Toxicol. Lett. 1995; 82–83, 627–632
   Google Scholar
• Weinstein I. B., Jeffrey A. M., Leffler S., Pulkrabek P., Yamasaki H., Grunberger D. Interactions between Polycyclic Aromatic Hydrocarbons and Cellular Macromolecules. Polycyclic Hydrocarbons and Cancer, H. V. Gelboin, P. O.P. Ts'o. Academic Press, New York 1978; 4–36
   Google Scholar
• Eberhart J., Coffing S. L., Anderson J. N., Marcus C., Kalogeris T. J., Baird W. M., Park S. S., Gelboin H. V. The Time-Dependent Increase in the Binding of Benzo[a]pyrene to DNA through (+)-anti-benzo[a]pyrene-7,8-diol-9,10-epoxide in Primary Rat Hepatocyte Cultures Results from Induction of Cytochrome P450IA1 by Benzo[a]pyrene Treatment. Carcinogenesis 1992; 13: 297–301
   PubMed Web of Science ®Google Scholar
• Todorovic R., Devanesan P. D., Cavalieri E. L., Rogan E. G., Park S. S., Gelboin H. V. A Monoclonal Antibody to Rat Liver Cytochrome P450 IIC11 Strongly and Regiospecifically Inhibits Constitutive Benzo[a]pyrene Metabolism and DNA Binding. Mol. Carcinog. 1991; 4: 308–314
   PubMed Web of Science ®Google Scholar
• Yang H., Mazur-Melnyk M., de Boer J. G., Glickman B. W. A Comparison of Mutational Specificity of Mutations Induced by S9-activated B[a]P and Benzo[a]pyrene-7,8-diol-9,10-epoxide at the Endogenous aprt Gene in CHO Cells. Mutat. Res. 1999; 423: 23–32
   PubMed Web of Science ®Google Scholar
• Shukla R., Geacintov N. E., Loechler E. L. The Major, N2-dG Adduct of (+)-anti-B[a]PDE induces G → A Mutations in a 5′-AGA-3′ Sequence Context. Carcinogenesis 1999; 20: 261–268
   PubMed Web of Science ®Google Scholar
• Rodriguez H., Loechler E. L. Mutational Spectra of the (+)-anti-diol Epoxide of Benzo[a]pyrene in a supF Gene of an Escherichia coli Plasmid: DNA Sequence Context Influences Hotspots, Mutational Specificity and the Extent of SOS Enhancement of Mutagenesis. Carcinogenesis 1993; 14: 373–383
   PubMed Web of Science ®Google Scholar
• Rodriguez H., Loechler E. L. Mutagenesis by the (+)-anti-diol Epoxide of Benzo[a]pyrene: What Controls Mutagenic Specificity?. Biochemistry 1993; 32: 1759–69
   PubMed Web of Science ®Google Scholar
• Mackay W., Benasutti M., Drouin E., Loechler E. L. Mutagenesis by the Major Adduct of Activated Benzo[a]pyrene, (+)-anti-BP-N2-Gua, When Studied in an Escherichia coli Plasmid Using Site-Directed Methods. Carcinogenesis 1992; 13: 1415–1425
   PubMed Web of Science ®Google Scholar
• Shukla R., Liu Y., Geacintov N., Loechler E. L. The Major, N2-dG Adduct of (+)-anti-B[a]PDE Shows a Dramatically Different Mutagenic Specificity (Predominantly, G → A) in a 5-GCT-3 Sequence Context. Biochemistry 1997; 36: 10256–10261
   PubMed Web of Science ®Google Scholar
• Shukla R., Jelinsky S., Liu T., Geacintov N. E., Loechler E. L. How Stereochemistry Affects Mutagenesis by N2-dG Adducts of B[a]PDE: Configuration of the Adduct Bond Is More Important than of the Hydroxyl Groups. Biochemistry 1997; 36: 13263–13269
   PubMed Web of Science ®Google Scholar
• Ross R. The Pathogenesis of Atherosclerosis, a Perspective for the 1990s. Nature 1993; 362: 801–809
   PubMed Web of Science ®Google Scholar
• Benditt E. P., Benditt J. M. Evidence for a Monoclonal Origin of Human Atherosclerotic Plaques. Proc. Natl. Acad. Sci. USA 1973; 70: 1753–1756
   PubMed Web of Science ®Google Scholar
• Schwartz S. M., Murry C. E. Proliferation and the Monoclonal Origins of Atherosclerotic Lesions. Annu. Rev. Med. 1998; 49: 437–460
   PubMed Web of Science ®Google Scholar
• Ramos K. S., Parrish A. R. Growth-Related Signaling as a Target of Toxic Insult in Vascular Tissue. Life Sciences 1995; 57: 627–635
   PubMed Web of Science ®Google Scholar
• Zhang Y., Ramos K. S. The Induction of Proliferative Vascular Smooth Muscle Cell Phenotypes by Benzo[a]pyrene Does Not Involve Mutational Activation of ras Genes. Mutat. Res. 1997; 373: 285–292
   PubMed Web of Science ®Google Scholar
• Sadhu D. N., Merchant M., Safe S. H., Ramos K. S. Modulation of Protooncogene Expression in Rat Aortic Smooth Muscle Cells by Benzo[a]pyrene. Arch. Biochem. Biophys. 1993; 300: 124–131
   PubMed Web of Science ®Google Scholar
• Ramos K. S., Zhang Y., Sadhu D. N., Chapkin R. C. The Induction of Proliferative Phenotypes in Vascular Smooth Muscle Cells by Benzo[a]pyrene Is Characterized by Upregulation of Phosphatidylinositol Metabolism and c-Ha-ras Gene Expression. Arch. Bioch. Biophys. 1996; 332: 213–222
   PubMed Web of Science ®Google Scholar
• Serabjit-Singh C. J., Bend J. R., Philpot R. M. Cytochrome P-450 Monooxygenase System Localization in Smooth Muscle of Rabbit Aorta. Mol. Pharmacol. 1985; 28: 72–79
   PubMed Web of Science ®Google Scholar
• Thirman M. J., Albrecht J. H., Krueger M. A., Erickson R. R., Cherwitz D. L., Park S. S., Gelboin H. V., Holtzman J. L. Induction of Cytochrome CYPIA1 and Formation of Toxic Metabolites of Benzo[a]pyrene by Rat Aorta: A Possible Role in Atherogenesis. Proc. Natl. Acad. Sci. USA 1994; 91: 5397–5401
   PubMed Web of Science ®Google Scholar
• Bond J. A., Omiecinski C. J., Juchau M. R. Kinetics, Activation, and Induction of Aortic Mono-Oxygenases—Biotransformation of Benzo[a]pyrene. Biochem. Pharmacol. 1979; 28: 305–311
   PubMed Web of Science ®Google Scholar
• Shanlin F. U., Davies M. J., Stocker R., Dean R. T. Evidence for Roles of Radicals in Protein Oxidation in Advanced Human Atherosclerotic Plaque. Biochem. J. 1998; 333: 519–525
   PubMed Web of Science ®Google Scholar
• Hough J. L., Baird M. B., Sfeir G. T., Pacini C. S., Darrow D., Wheelock C. Benzo[a]pyrene Enhances Atherosclerosis in White Carneau and Show Racer Pigeons. Arterioscleros. Thromb. 1993; 13: 1721–1727
   PubMedGoogle Scholar
• Zwijsen R. M., van Kleef E. M., Alink G. M. A Comparative Study on the Metabolic Activation of 3,4-benzo[a]pyrene to Mutagens by Aorta Smooth Muscle Cells of Rat and Rabbit. Mutat. Res. 1990; 230: 111–117
   PubMed Web of Science ®Google Scholar
• Kitamura S. Effects of Cigarette Smoking on Metabolic Events in the Lung. Environ. Health Perspect. 1987; 72: 283–296
   PubMed Web of Science ®Google Scholar
• Ramos K. S., Chacon E., Acosta D., Jr. Toxic Responses of the Heart and Vascular Systems. Casarett and Doull's Toxicology, The Basic Science of Poisons, C. D. Klaassen. McGraw-Hill, New York 1996; 487–527
   Google Scholar
• Juchau M. R., Lee Q. P., Fantel A. G. Xenobiotics Biotransformation/Bioactivation in Organogenesis-Stage Conceptal Tissues: Implications for Embryotoxicity and Teratogenesis. Drug Metab. Rev. 1992; 24: 195–238
   PubMed Web of Science ®Google Scholar
• Winn L. M., Wells P. G. Free Radical-Mediated Mechanisms of Anticonvulsant Teratogenicity. Eur. J. Neurol. 1995; 2(Suppl. 4)5–29
   PubMedGoogle Scholar
• Fantel A. G. Reactive Oxygen Species in Development Toxicity: Review and Hypothesis. Teratology 1996; 53: 196–217
   PubMedGoogle Scholar
• Wells P. G., Winn L. M. Biochemical Toxicology of Chemical Teratogeneseis. Crit. Rev. Biochem. Mol. Biol. 1996; 31: 1–40
   PubMed Web of Science ®Google Scholar
• Wells P. G., Winn L. M. The Role of Biotransformation in Development Toxicity. Comprehensive Toxicology, vol. 10: Reproductive and Endocrine Toxicology, I. G. Sipes, C. A. McQueen, A. J. Gandolphi. Elsevier, Amsterdam 1997; 489–507
   Google Scholar
• Wells P. G., Kim P. M., Nicol C. J., Parman T., Winn L. M. Reactive Intermediates. Handbook of Experimental Pharmacology Drug Toxicity in Embryonic Development, R. J. Kavlock, G. P. Daston. Springer-Verlag, Berlin 1997; 451–516
   Google Scholar
• Wells P. G., Kim P. M., Laposa R. R., Nicol C. J., Parman T., Winn L. M. Oxidative Damage in Chemical Teratogenesis. Mutat. Res. 1997; 396: 65–78
   PubMed Web of Science ®Google Scholar
• Winn L. M., Wells P. G. Evidence of Embryonic Prostaglandin H Synthase-Catalyzed Bioactivation and Reactive Oxygen Species-Mediated Oxidation of Macromolecules in Phenytoin and Benzo[a]pyrene teratogenesis. Free Rad. Biol. Med. 1997; 22: 607–621
   PubMed Web of Science ®Google Scholar
• Winn L. M., Wells P. G. Phenytoin-Initiated DNA Oxidation in Murine Embryo Culture, and Embryoprotection by the Antioxidative Enzymes Superoxide Dismutase and Catalase: Evidence for Reactive Oxygen Species Mediated DNA Oxidation in the Molecular Mechanism of Phenytoin Teratogenicity. Mol. Pharmacol. 1995; 48: 112–120
   PubMed Web of Science ®Google Scholar
• Wells P. G., Obilo F. C., de Morais S. M.F. Benzo[a]pyrene Embryopathy in Rats Genetically Deficient in Bilirubin UDP-Glucuronyl Transferase. FASEB J. 1989; 3: A1025
   Google Scholar
• Gregus Z., Klaassen C. D. Mechanisms of Toxicity. Casarett and Doull's Toxicology, The Basic Science of Poisons, C. D. Klaassen. McGraw-Hill, New York 1996; 35–74
   Google Scholar
• Nicol C. J., Harrison M. L., Laposa R. R., Gimelshtein I. L., Wells P. G. A Teratologic Suppressor Role for p53 in Benzo[a]pyrene-Treated Transgenic p53-deficient Mice. Nature Genet. 1995; 10: 181–187
   PubMed Web of Science ®Google Scholar
• Harrison M. L., Nicol C. J., Wells P. G. Tumor Suppressor Genes and Chemical Teratogenesis: Benzo[a]pyrene Embryopathy and Cytochromes P-450. Activities in p53-Deficient Transgenic Mice. Toxicologist 1994; 14: 246
   Google Scholar
• Lu L. J., Anderson L. M., Jones A. B., Moskal T. J., Salazar J. J., Hokanson J. A., Rice J. M. Persistence, Gestation Stage-Dependent Formation and Interrelationship of Benzo[a]pyrene-Induced DNA Adducts in Mothers, Placentae and Fetuses of Erythrocebus Patas Monkeys. Carcinogenesis 1993; 14: 1805–1813
   PubMed Web of Science ®Google Scholar
• Iannaccone P. M., Fahl W. E., Stols L. Reproductive Toxicity Associated with Endometrial Cell Mediated Metabolism of Benzo[a]pyrene: A Combined in vitro in vivo Approach. Carcinogenesis 1984; 5: 1437–1442
   PubMed Web of Science ®Google Scholar
• Arnould J. P., Verhoest P., Bach V., Libert J. P., Belegaud J. Detection of Benzo[a]pyrene-DNA Adducts in Human Placenta and Umbilical Cord Blood. Hum. Exp. Toxicol. 1997; 16: 716–721
   PubMed Web of Science ®Google Scholar
• Sanyal M. K., Li Y. L., Biggers W. J., Satish J., Barnea E. R. Augmentation of Polynuclear Aromatic Hydrocarbon Metabolism of Human Placental Tissues of First-Trimester Pregnancy by Cigarette Smoke Exposure. Am. J. Obstet. Gynecol. 1993; 168: 1587–1597
   PubMed Web of Science ®Google Scholar
• Shendrikova I. A., Ivanov-Golitsyn M. N., Likchachev A. Y. The Transplacental Penetration of Benzo[a]pyrene in Mice. Vopr. Onkologii 1974; 20: 53–56
   PubMed Web of Science ®Google Scholar
• Srivastava V. K., Chauhan S. S., Srivastava P. K., Kumar V., Misra U. K. Fetal Translocation and Metabolism of PAH Obtained from Coal Fly Ash Given Intratracheally to Pregnant Rats. J. Toxicol. Environ. Health 1986; 18: 459–469
   PubMed Web of Science ®Google Scholar
• Legraverend C., Guenther T. M., Nebert D. W. Importance of the Route of Administration for Genetic Differences in Benzo[a]pyrene-Induced in utero Toxicity and Teratogenicity. Teratology 1984; 29: 35–47
   PubMedGoogle Scholar
• Mackenzie K. M., Angevine D. M. Infertility in Mice Exposed in utero to Benzo[a]pyrene. Biol. Reprod. 1981; 24: 183–191
   PubMed Web of Science ®Google Scholar
• Shum S., Jensen N. M., Nebert D. W. The Murine Ah Locus: In utero Toxicity and Teratogenesis Associated with Genetic Differences in Benzo[a]pyrene Metabolism. Teratology 1979; 20: 365–376
   PubMedGoogle Scholar
• Payne. The Pathological Effects of the Intraperitoneal Injection of 3,4-benzopyrene into Rats and Mice. Br. J. Cancer 1958; 12: 65–74
   PubMed Web of Science ®Google Scholar
• Urso P., Gengozian N. Depressed Humoral Immunity and Increased Tumor Incidence in Mice Following in utero Exposure to Benzo[a]pyrene. J. Toxicol. Environ. Health 1980; 6: 569–576
   PubMed Web of Science ®Google Scholar
• Bulay O. M., Wattenberg L. W. Carcinogenic Effects of Polycyclic Hydrocarbon Carcinogen Administration to Mice During Pregnancy on the Progeny. J. Natl. Cancer Inst. 1971; 46: 397–402
   PubMed Web of Science ®Google Scholar
• Soyka L. F. Hepatic Drug Metabolizing Enzyme Activity and Tumorigenesis in Mice Following Perinatal Exposure to Benzo[a]pyrene. Pediatr. Pharmacol. 1980; 1: 85–96
   PubMedGoogle Scholar
• Sheveleva G. A. On the Effect of 3,4-benzpyrene on the Development of the Foetus Applied at Different Stages of Gestation. Gig. Tr. Prof. Zabol. 1978; 7: 54
   Google Scholar
• This paper was referred by Dr. Daniel Acosta, Ph.D., University of Cincinnati, Cincinnati, OH 45267.
   Google Scholar